Publicaciones
-
Pascual-Pastó G, Gene-Olaciregui N, Vilà-Ubach M, Paco-Mercader S, Monterrubio C, Rodriguez E, Winter U, Batalla-Vilacís M, Català-Mora J, Salvador-Hernandez H, Parareda A, Schaiquevich P, Suñol M, Mora J, Lavarino C, de Torres C, Chantada G and Carcaboso AM.
Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination
CANCER LETTERS . 380(1): 10-19. Nº de citas: 27
-
Mora J, Cruz-Martínez O, Lavarino C, Rios J, Vancells M, Parareda A, Salvador-Hernandez H, Suñol M, Carrasco-Torrents R, Guillen-Quesada A, Mañé S and de Torres C.
Results of induction chemotherapy in children older than 18 months with stage-4 neuroblastoma treated with an adaptive-to-response modified N7 protocol (mN7)
CLINICAL & TRANSLATIONAL ONCOLOGY . 17(7): 521-529. Nº de citas: 14
-
Parareda A, Català-Mora J, Carcaboso AM, Sola T, Cruz-Martínez O, Díaz J, Salvador-Hernandez H, de Torres C, Álvarez-Sampons A, Suñol M, Vinent-Genestar J, Guimaraens L, Prat-Bartomeu J and Mora J.
Intra-arterial chemotherapy for retinoblastoma. Challenges of a prospective study
ACTA OPHTHALMOLOGICA . 92(3): 209-215. Nº de citas: 27
-
Mora J, de Torres C, Parareda A, Torner-Rubies F, Galván P, Rodriguez E, Cardesa-Salzmann TM, Salvador-Hernandez H, Suñol M, Huguet R and Cruz-Martínez O.
Treatment of Ewing Sarcoma Family of Tumors With a Modified P6 Protocol in Children and Adolescents
PEDIATRIC BLOOD & CANCER . 57(1): 69-75. Nº de citas: 13
-
CastilloSD, Perosanz X, Ressler AK, Ivars M, Rodriguez J, Rovira-Zurriaga C, Nola EM, Llena J, Grego-Bessa J, Roldan-Molina M, Arnau R, Martínez-Romero A, Barber-Martínez de la Torre I, Miguel Bejarano Serrano, Vicente-Villa MA, Celis-Passini V, Salvador-Hernandez H, Mora J, Marchuk DA, Baselga E and Graupera M.
Somatic uniparental disomy of PTEN in endothelial cells causes vascular malformations in patients with PTEN Hamartoma Tumor Syndrome.
CANCER DISCOVERY . : .
-
Casano-Sancho P, Molina-Giraldo PX, Valls-Lafon A and Salvador-Hernandez H.
Growth hormone excess in children with neurofibromatosis and optic pathway glioma, an underdiagnosed condition: experience with long-acting treatment.
EUROPEAN JOURNAL OF ENDOCRINOLOGY . : .